Starway Medical

Starway Medical Technology Inc. (referred to as "Starway Medical") was established in 2002 and has always been committed to providing safe, effective, high-quality, and reliable products and services in the field of vascular intervention, helping patients regain a healthy life. Since its establishment, Starway Medical has relied on its independently developed integrated platform for research, production, and sales to provide solutions in clinical treatment areas such as congenital heart defects, migraines, and prevention of cardioembolic stroke. In 2003 and 2009, the company launched China-produced occluders for congenital heart disease and the first patent foramen ovale (PFO) occluder product in China, respectively. In 2011, it received the second prize of the National Science and Technology Progress Award. In the future, with deep expertise in specialized fields, Starway Medical will focus on the domestic market while looking towards overseas markets, bringing hope for health to more patients worldwide.